metricas
covid
Buscar en
Revista Española de Geriatría y Gerontología
Toda la web
Inicio Revista Española de Geriatría y Gerontología Reacciones adversas a medicamentos de pronóstico grave en ancianos instituciona...
Información de la revista
Vol. 38. Núm. 4.
Páginas 193-197 (enero 2003)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 38. Núm. 4.
Páginas 193-197 (enero 2003)
Acceso a texto completo
Reacciones adversas a medicamentos de pronóstico grave en ancianos institucionalizados
Adverse drug reactions with poor prognosis in institutionalized elderly
Visitas
4380
E. Puchea,
Autor para correspondencia
epuche@ugr.es

Correspondencia: Departamento de Farmacología y Terapéutica. Facultad de Medicina. Universidad de Granada. Avda. Madrid, 11. 18012 Granada. España
, J.D. Lunab, J. Garcíac, L. Góngorad
a Profesor Titular. Departamento de Farmacología y Terapéutica. Facultad de Medicina. Universidad de Granada. Granad
b Profesor Titular. Departamento de Bioestadística. Facultad de Medicina. Universidad de Granada. Granada
c Servicio de Geriatría. Hospital Universitario San Rafael. Granada
d Servicio de Geriatría. Residencia La Milagrosa Armilla. Granada. España
Este artículo ha recibido
Información del artículo
Resumen
Objetivo

Estudiar las reacciones adversas a medicamentos (RAM) de pronóstico grave en ancianos institucionalizados.

Metodología

Se realizó un estudio epidemiológico prospectivo durante 12 meses recogiendo, de historias clínicas elegidas al azar de ancianos institucionalizados en 5 residencias de Granada y su área metropolitana, información relativa a edad, sexo, número y tipo de medicamentos, diagnóstico y grado de validez fisicopsíquica de los ancianos, RAM con el fármaco imputado y su pronóstico. Como pruebas estadísticas se usaron la de Wilcoxon para variables numéricas y la de Fisher para las cualitativas, y se empleó para el análisis el paquete estadístico STATA versión 7.0.

Resultados

En las 400 historias clínicas consultadas se detectaron 75 RAM, de las que un 33% fueron graves. Los fármacos más implicados fueron los antiinflamatorios no esteroideos (AINE), antidiabéticos y digoxina. Cuatro ancianos requirieron hospitalización por causa de una RAM grave consistente en dos intoxicaciones digitálicas y dos hemorragias digestivas por AINE. No hallamos diferencias estadísticamente significativas entre RAM graves y edad, sexo, número de diagnósticos o grado de validez fisicopsíquica de los ancianos; en cambio, sí hallamos una débil asociación con el número de medicamentos (p = 0,061). El 88% de las RAM graves fueron del tipo A, dependientes de la dosis y previsibles.

Conclusiones

Los ancianos institucionalizados sufren RAM graves en una elevada proporción por AINE, antidiabéticos y digoxina, y en su mayoría son evitables. Destacamos el interés de este tipo de trabajos.

Palabras clave:
Ancianos
Residencia
Reacciones adversas a medicamentos (RAM) graves
Abstract
Objective

To investigate adverse drug reactions (ADR) with a serious prognosis in institutionalized older persons.

Methodology

This prospective epidemiological study covered a 12-month period (January-December, 2001) during which we collected information from randomly selected medical records of elderly persons living in five nursing homes in Granada, Spain. The variables recorded were age, sex, number and type of drugs, diagnosis, physical and cognitive functioning, ADR, medication involved, and prognosis. Wilcoxon’s test was used for numerical variables and Fisher’s test was used for qualitative variables. All statistical analyses were performed with the STATA 7.0. program.

Results

Four hundred medical records were reviewed and 75 ADR were found. Thirty-three percent of the ADR were serious. The medications most frequently involved were non-steroidal anti-inflammatory drugs (NSAIDs) (48%), antidiabetic drugs (16%) and digoxin (12%). Four elderly individuals were hospitalized because of a serious ADR: two due to digoxin-induced cardiac arrhythmia and two due to NSAID-induced digestive tract bleeding. There were no statistically significant differences in serious ADR according to age, sex, diagnoses, or degree of physical disability or cognitive impairment. A weak relationship was found between serious ADR and the number of drugs (p = 0.061). Nearly all (88%) ADR were type A, dose-dependent, and preventable.

Conclusions

Serious adverse drug reactions in elderly persons living in institutions are frequent and are often caused by NSAIDs, antidiabetic drugs and digoxin. Most cases can be prevented. We highlight the importance of this type of study.

Key words:
Elderly
Nursing home
Serious adverse drug reactions
El Texto completo está disponible en PDF
Bibliografía
[1.]
N. Hurwitz, O. Wade.
Predisposing factors in adverse reactions to drug.
BMJ, 1 (1969), pp. 536-553
[2.]
J. Doucet, C. Capet, A. Jégo, C. Trivalle, D. Noel, P. Chassagne, et al.
Les effets indésirables des medicaments chez le sujet agé: épidemiologie et prevention.
Press Med, 28 (1999), pp. 1789-1793
[3.]
L.J. Veehof, R.E. Steward, B. Meyboom de Jong, F.M. Haaijer-Ruskamp.
Adverse drug reactions and polypharmacy in the elderly in general practice.
Eur J Clin Pharmacol, 55 (1999), pp. 533-536
[4.]
D. Bates, D. Cullen, N. Laird, L. Petersen, S. Small, D. Servi, et al.
Incidence of adverse drug events and potential adverse drug events.
JAMA, 274 (1995), pp. 29-34
[5.]
T.R. Einarsson.
Drug-related hospital admissions.
Ann Pharmacoter, 27 (1993), pp. 832-840
[6.]
T. Hutchinson, K.M. Flegel, M.S. Kramer, D.G. Leduc, M.S. Hopimokong.
Frecuency, severity and risk factor for adverse drug reactions in adult out patients: a prospective study.
J Chron Dis, 39 (1986), pp. 533-542
[7.]
D. Bonn.
Adverse drug reactions remain a major cause of death.
[8.]
L. Nolan, K. O’Mally.
Prescribing for the elderly. Sensitivity of the elderly to adverse drug reactions.
J Am Geriatr Gerontol Soc, 36 (1988), pp. 142-149
[9.]
L. Bjerrum, J. Sogaad, J. Hallas, J. Kragstrup.
Polypharmacy: correlations with sex age and drug regimen. A prescription database study.
Eur J Clin Pharmacol, 54 (1998), pp. 197-202
[10.]
A. Hammerlein, H. Derendorf, D. Lowenthal.
Pharmacokinetic and pharmacodynamic changes in the elderly.
Clin Pharmacokinet, 35 (1998), pp. 49-64
[11.]
J. Gurwitz, T. Field, J. Avorn, D. McCormick, S. Jain, M. Eckler, et al.
Incidence and preventability of adverse drug events in nursing homes.
Am J Med, 109 (2000), pp. 87-94
[12.]
J. Walker, H. Wynne.
Review: the frecuency and severity of adverse drug reactions in elderly people.
Age Ageing, 23 (1994), pp. 255-259
[13.]
P. Cutroneo, S. Greco, G. Cucinotta, V. Arcoraci, A.P. Caputi.
Spontaneous reporting of adverse drug reactions in elderly patients in Sicily (Italy).
Pharmacol Res, 40 (1999), pp. 41-46
[14.]
P. Atkin, P. Veitch, E. Veitch, S. Ogle.
The epidemiology of serious adverse drug reactions among the elderly.
Drugs Aging, 14 (1999), pp. 141-152
[15.]
H.J. Beijer, C.J. De Blaey.
Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies.
Pharm World Sci, 24 (2002), pp. 46-54
[16.]
M. Chan, F. Nicklason, J.H. Vial.
Adverse drug events as a cause of hospital admission in the elderly.
Intern Med J, 31 (2001), pp. 199-205
[17.]
P. Carbonin, M. Pahor, R. Bernabei, A. Sgadari.
Is age an independent risk factor of adverse drug ractions in hospitalized medical patients?.
J Am Geriatr Soc, 39 (1991), pp. 1093-1099
[18.]
C. Naranjo, U. Busto, M. Sellers, P. Sandor, I. Ruiz, E.A. Roberts, et al.
A method for estimating the probability of adverse drug reactions.
Clin Pharmacol Ther, 30 (1981), pp. 239-245
[19.]
OMS.
Technical Report Series n.° 498.
[20.]
E. Heele, J. Riley, D. Layton, L. Wilton, S.A. Shakir.
Prescription-event monitoring and reporting of adverse drug reactions.
Lancet, 358 (2001), pp. 1872-1873
[21.]
G. Fradet, X. Legac, T. Charlois, T. Ponge, S. Cottin.
Pathologie iatrogêne médicamenteuse aprês 65 ans, responsable d’une hospitalisation. Etude étrospective sur 1 an dans una service de médicine interne.
Rev Méd Intern, 17 (1996), pp. 456-460
[22.]
S. Bruneau, C. Bruhat, L. Lagarce, P. Lainé-Cessac.
Etude rétrospective de la Iatrogénie médicamenteuse chez le sujet agé: expérience d’un centre régional de pharmacovigilance.
Therapie, 56 (2001), pp. 785-791
[23.]
M. Griffin, J.M. Piper, J.R. Daugherty, M. Snowden, W. Ray.
Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons.
Ann Intern Med, 114 (1991), pp. 257-263
[24.]
S. Gabriel, L. Jaakkimainen, C. Bombardier.
Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis.
Ann Intern Med, 115 (1991), pp. 787-796
[25.]
R. Tamblyn, L. Berkson, D. Dauphinee, D. Gayton, R. Grad, A. Huang, et al.
Unnecessary prescribing of NSAIDs and the manegement of NSAID-related gastropathy in medical practice.
Ann Intern Med, 127 (1997), pp. 429-438
[26.]
M. Pahor, J. Guralnik, G. Gambassi, R. Bernabei, L. Carosella, P. Carbonin.
The impact of age on risk of adverse drug reactions to digoxin.
J Clin Epidemiol, 46 (1993), pp. 1305-1314
[27.]
M. Gosselink, D. Van Veldhuisen, H. Crijns.
When, and when not to use digoxin in the elderly.
Drugs Aging, 10 (1997), pp. 411-420
[28.]
P. Marik, L. Fromm.
A case series of hospitalized patients with elevated digoxin levels.
Am J Med, 105 (1998), pp. 110-115
[29.]
C.L. Le Jeunne, F.C. Hugues.
Interactions médicamenteuses et personnes agées.
Therapie, 50 (1995), pp. 247-252
[30.]
R.M. Seymour, P.A. Routledge.
Important drug-drug interactions in the elderly.
Drugs Aging, 12 (1998), pp. 485-494
[31.]
G. Simpson, H.P. Edmond, J. Sramek.
Adverse effects of antipsichotic agents.
Drugs, 21 (1981), pp. 138-151
[32.]
H.S. Lau, C. Florax, A.J. Porsius, A. De Boer.
The completeness of medication histories in hospital medical records of patients admitted to general internal medicine wards.
Br J Clin Pharmacol, 49 (2000), pp. 597-603
[33.]
R. Aparasu, J. Mort.
Inappropriate prescribing for the elderly: beers criteria based review.
Ann Pharmacother, 34 (2000), pp. 338-346
[34.]
B. Huang, K. Bachmann, X. He, R. Chen, J. McAllister, T. Wang.
Inappropriate prescriptions for aging population of United States: an analysis of the National Ambulatory Medical Survey 1997.
Pharmacoepidemiol Drug Saf, 11 (2002), pp. 127-134
Copyright © 2003. Sociedad Española de Geriatría y Gerontología
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos